Allscripts Putting More Treatment Options at the Physicians Fingertips at the Cancer Treatment Centers of America

The Cancer Treatment Centers of America has integrated a new system called Allscripts. They have partnered with NantHealth and Allscripts so that this system can provide the best of care for each patient at the Cancer Treatment Centers of America. This system provides different treatment options specific to the cancer. It shows comparisons between the treatment options as well as the toxicology reports and research to back each treatment option.

As stated on WebMD, this system is available to all physicians at the Cancer Treatment Centers of America. Each treatment option has been reviewed by their peers and backed by an advisory board that consists of nationally recognized oncology experts. This allows patients to take control of their health as they can review each treatment option with their physician and decide what is the best course of action specific to their cancer treatment needs.

Once the physician and the patient decide their course of treatment, the physician can order the treatment through Allscripts. This system keeps the physicians up to date on the latest treatment options available and the effectiveness each treatment offers.

The Cancer Treatment Centers of America is a state of the art facility that specializes in cancer only. This allows for the physicians to focus on the different types of cancers so that they can provide the best treatment options to their patients. Treatment options are tailored to each patient because each patient’s needs are different. Their goal is to focus on the quality of life for the patient while they treat their disease.

The Cancer Treatment Centers of America’s physicians treat each patient like they are family. They know that a cancer diagnosis is scary and they want each patient to know that they are providing each one of the patients with the best care available with the latest, up to date treatment options.

For more information follow CTCA on Twitter.

Leave a Reply

Your email address will not be published. Required fields are marked *